Skip to main content
Clinical Trials/NCT03816410
NCT03816410
Completed
Not Applicable

Influence of Left Atrial Appendage Amputation on Natriuretic Peptides - a Randomized Controlled Trial

University of Giessen1 site in 1 country21 target enrollmentMay 1, 2015

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Atrial Fibrillation
Sponsor
University of Giessen
Enrollment
21
Locations
1
Primary Endpoint
Serum levels of proANP and BNP until 800days post surgery
Status
Completed
Last Updated
7 years ago

Overview

Brief Summary

Surgical amputation of the left atrial appendage (LAA) is an established intervention during surgical atrial fibrillation (AF) therapy. However, its effects on the endocrine function of the left atrium are unclear. This study aims to quantify the serum levels of natriuretic peptides in patients who undergo concomitant surgical AF ablation with or without LAA amputation.

Registry
clinicaltrials.gov
Start Date
May 1, 2015
End Date
December 1, 2018
Last Updated
7 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Indication for concomitant AF therapy during cardiac surgery with cardiopulmonary bypass

Exclusion Criteria

  • Lack of informed consent

Outcomes

Primary Outcomes

Serum levels of proANP and BNP until 800days post surgery

Time Frame: 800days

Study Sites (1)

Loading locations...

Similar Trials